Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics

Abstract Intravitreal injection (IVI) of anti-vascular endothelial growth factor (VEGF) is the standard treatment modality in various types of retinal diseases. However, endophthalmitis remains the most serious complication. Despite the lack of evidence that antibiotics prevent endophthalmitis, topi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Masakazu Morioka, Yoshihiro Takamura, Kazuki Nagai, Shigeo Yoshida, Junya Mori, Masaru Takeuchi, Tomoko Sawada, Kumiko Sone, Hisashi Fukuyama, Sentaro Kusuhara, Tsutomu Yasukawa, Tomoya Murakami, Hitoshi Tabuchi, Daisuke Nagasato, Takao Hirano, Tetsuo Ueda, Tatsuya Jujo, Hirofumi Sasajima, Yoshinori Mitamura, Kunihiro Ishikawa, Masaru Inatani
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9201ac3ac32147808a34465d07612582
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9201ac3ac32147808a34465d07612582
record_format dspace
spelling oai:doaj.org-article:9201ac3ac32147808a34465d076125822021-12-02T12:40:40ZIncidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics10.1038/s41598-020-79377-w2045-2322https://doaj.org/article/9201ac3ac32147808a34465d076125822020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79377-whttps://doaj.org/toc/2045-2322Abstract Intravitreal injection (IVI) of anti-vascular endothelial growth factor (VEGF) is the standard treatment modality in various types of retinal diseases. However, endophthalmitis remains the most serious complication. Despite the lack of evidence that antibiotics prevent endophthalmitis, topical antibiotics are still used routinely in Japan. We conducted a retrospective multicenter study by analyzing records from patients who underwent IVI of anti-VEGF agents with or without antibiotic treatment. In the analysis of a total of 147,440 eyes, the incidence of endophthalmitis was 0.007%: 0.005% with no use of antibiotics, 0.009% with antibiotic pretreatment, 0.012% with posttreatment, and 0.005% with pre- and posttreatment. There was no statistically significant difference among the four groups (chi-square test, p = 0.57). Most facilities used masks, sterilized gloves, and drapes. Nine of the 10 eyes that developed endophthalmitis received topical antibiotics, and all infected eyes underwent IVI with aflibercept, not the prefilled syringe delivery system. In four patients who received multiple IVI, the detection of causative bacteria revealed resistance to used antibiotics. Data from this large population, treated with or without antibiotics, suggests that antibiotic prophylaxis does not reduce the rate of endophthalmitis after IVI.Masakazu MoriokaYoshihiro TakamuraKazuki NagaiShigeo YoshidaJunya MoriMasaru TakeuchiTomoko SawadaKumiko SoneHisashi FukuyamaSentaro KusuharaTsutomu YasukawaTomoya MurakamiHitoshi TabuchiDaisuke NagasatoTakao HiranoTetsuo UedaTatsuya JujoHirofumi SasajimaYoshinori MitamuraKunihiro IshikawaMasaru InataniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-6 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Masakazu Morioka
Yoshihiro Takamura
Kazuki Nagai
Shigeo Yoshida
Junya Mori
Masaru Takeuchi
Tomoko Sawada
Kumiko Sone
Hisashi Fukuyama
Sentaro Kusuhara
Tsutomu Yasukawa
Tomoya Murakami
Hitoshi Tabuchi
Daisuke Nagasato
Takao Hirano
Tetsuo Ueda
Tatsuya Jujo
Hirofumi Sasajima
Yoshinori Mitamura
Kunihiro Ishikawa
Masaru Inatani
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
description Abstract Intravitreal injection (IVI) of anti-vascular endothelial growth factor (VEGF) is the standard treatment modality in various types of retinal diseases. However, endophthalmitis remains the most serious complication. Despite the lack of evidence that antibiotics prevent endophthalmitis, topical antibiotics are still used routinely in Japan. We conducted a retrospective multicenter study by analyzing records from patients who underwent IVI of anti-VEGF agents with or without antibiotic treatment. In the analysis of a total of 147,440 eyes, the incidence of endophthalmitis was 0.007%: 0.005% with no use of antibiotics, 0.009% with antibiotic pretreatment, 0.012% with posttreatment, and 0.005% with pre- and posttreatment. There was no statistically significant difference among the four groups (chi-square test, p = 0.57). Most facilities used masks, sterilized gloves, and drapes. Nine of the 10 eyes that developed endophthalmitis received topical antibiotics, and all infected eyes underwent IVI with aflibercept, not the prefilled syringe delivery system. In four patients who received multiple IVI, the detection of causative bacteria revealed resistance to used antibiotics. Data from this large population, treated with or without antibiotics, suggests that antibiotic prophylaxis does not reduce the rate of endophthalmitis after IVI.
format article
author Masakazu Morioka
Yoshihiro Takamura
Kazuki Nagai
Shigeo Yoshida
Junya Mori
Masaru Takeuchi
Tomoko Sawada
Kumiko Sone
Hisashi Fukuyama
Sentaro Kusuhara
Tsutomu Yasukawa
Tomoya Murakami
Hitoshi Tabuchi
Daisuke Nagasato
Takao Hirano
Tetsuo Ueda
Tatsuya Jujo
Hirofumi Sasajima
Yoshinori Mitamura
Kunihiro Ishikawa
Masaru Inatani
author_facet Masakazu Morioka
Yoshihiro Takamura
Kazuki Nagai
Shigeo Yoshida
Junya Mori
Masaru Takeuchi
Tomoko Sawada
Kumiko Sone
Hisashi Fukuyama
Sentaro Kusuhara
Tsutomu Yasukawa
Tomoya Murakami
Hitoshi Tabuchi
Daisuke Nagasato
Takao Hirano
Tetsuo Ueda
Tatsuya Jujo
Hirofumi Sasajima
Yoshinori Mitamura
Kunihiro Ishikawa
Masaru Inatani
author_sort Masakazu Morioka
title Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
title_short Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
title_full Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
title_fullStr Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
title_full_unstemmed Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
title_sort incidence of endophthalmitis after intravitreal injection of an anti-vegf agent with or without topical antibiotics
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/9201ac3ac32147808a34465d07612582
work_keys_str_mv AT masakazumorioka incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT yoshihirotakamura incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT kazukinagai incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT shigeoyoshida incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT junyamori incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT masarutakeuchi incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT tomokosawada incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT kumikosone incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT hisashifukuyama incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT sentarokusuhara incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT tsutomuyasukawa incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT tomoyamurakami incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT hitoshitabuchi incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT daisukenagasato incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT takaohirano incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT tetsuoueda incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT tatsuyajujo incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT hirofumisasajima incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT yoshinorimitamura incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT kunihiroishikawa incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
AT masaruinatani incidenceofendophthalmitisafterintravitrealinjectionofanantivegfagentwithorwithouttopicalantibiotics
_version_ 1718393752387584000